InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,990.32
(
1.75%
)
Post# of 245499
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3156
Posts 961240
Boards Moderated 204
Alias Born 09/04/2000

mick

Member Level

Re: mick post# 207020

Wednesday, 09/11/2019 4:10:37 PM

Wednesday, September 11, 2019 4:10:37 PM

Post# of 245499
CytoDyn Inc. (OTC: CYDY) Nader Pourhassan, Ph.D, CEO.

CEO Dr. Nader Pourhassan updates investors on the latest developments for CytoDyn’s lead drug candidate, Leronlimab (PRO 140) for use as a Combination Therapy to treat HIV, and expecting FDA approval in early 2020.
Dr. Pourhassan also shares what’s ahead for the company’s pipeline for cancer indications
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up